Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OBETICHOLIC ACID vs OBINUTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OBETICHOLIC ACID vs OBINUTUZUMAB: Safety Overview

Metric OBETICHOLIC ACID OBINUTUZUMAB
Total FAERS Reports 6,716 14,189
Deaths Reported 529 1,919
Death Rate 7.9% 13.5%
Hospitalizations 1,402 5,419
Average Patient Age 61.9 yrs 63.8 yrs
% Female Patients 90.8% 41.7%
FDA Approval Date May 27, 2016 N/A
Manufacturer N/A Genentech, Inc.
Route N/A INTRAVENOUS
Marketing Status Discontinued Prescription